← Back to Search

Strength Training

Nutrition & Strength Training for Osteoporosis (INVEST Trial)

N/A
Waitlist Available
Led By Kristen Beavers, PhD, MPH, RD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 60-85 years
BMI=30-40 kg/m^2 or BMI 27.0-<30.0 kg/m^2 plus one risk factor
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months from baseline
Awards & highlights

INVEST Trial Summary

This trial will compare the effects of weight loss with and without additional interventions on indicators of bone health.

Who is the study for?
This trial is for adults aged 60-85 with a BMI between 27 and 40, who are stable in weight, can attend virtual sessions, and travel to visits. It's not for those with severe arthritis, recent major surgeries or metal implants in the hip/pelvis area, uncontrolled health conditions like hypertension or diabetes, heavy medication use including steroids or osteoporosis drugs, cognitive impairments, smokers or excessive drinkers.Check my eligibility
What is being tested?
The study compares three approaches to improve bone health and reduce fracture risk: weight loss alone (WL), WL plus wearing a weighted vest (Vest), and WL combined with resistance exercise training (RT). Participants will be assessed on how these methods affect their bones.See study design
What are the potential side effects?
Potential side effects may include discomfort from wearing the vest or muscle strain from resistance exercises. The diet changes could cause digestive adjustments. However, serious side effects are unlikely as this trial focuses on lifestyle interventions rather than medications.

INVEST Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 60 and 85 years old.
Select...
My BMI is between 27 and 40, and I may have a risk factor if it's under 30.
Select...
My BMI is between 27 and 40, and I haven't lost more than 5% of my weight in the last 6 months.

INVEST Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months from baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months from baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Change in distal radius areal bone mineral density (aBMD)
Change in femoral neck areal bone mineral density (aBMD)
Change in femoral neck volumetric bone mineral density (vBMD)
+7 more
Other outcome measures
Cognitive Assessment
Concentration of C-terminal telopeptide (CTX) (pg/mL)
Concentration of Procollagen 1 Intact N-Terminal Propeptide (P1NP) (ug/L)
+20 more

INVEST Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Weight Loss plus VestExperimental Treatment2 Interventions
Group II: Weight Loss Plus Resistance Exercise TrainingActive Control2 Interventions
Group III: Weight LossActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
weight loss program
2012
Completed Phase 3
~180
Vest
2020
N/A
~190

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,239 Previous Clinical Trials
1,004,033 Total Patients Enrolled
1 Trials studying Osteoporosis
187 Patients Enrolled for Osteoporosis
Kristen Beavers, PhD, MPH, RDPrincipal InvestigatorWake Forest University Health Sciences
1 Previous Clinical Trials
200 Total Patients Enrolled
Kristen Beavers, MDPrincipal InvestigatorWake Forest University Health Sciences
1 Previous Clinical Trials
200 Total Patients Enrolled

Media Library

Resistance Exercise Training (Strength Training) Clinical Trial Eligibility Overview. Trial Name: NCT04076618 — N/A
Osteoporosis Research Study Groups: Weight Loss plus Vest, Weight Loss Plus Resistance Exercise Training, Weight Loss
Osteoporosis Clinical Trial 2023: Resistance Exercise Training Highlights & Side Effects. Trial Name: NCT04076618 — N/A
Resistance Exercise Training (Strength Training) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04076618 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings in this research project?

"Clinicaltrials.gov states this clinical trial is still in search of participants as it was initially posted on August 12th 2020 and updated most recently on November 15th 2022."

Answered by AI

What are the criteria for qualifying individuals to partake in this experiment?

"This research seeks 150 older adults ages 60-85 who are overweight or obese and have not lost more than 5% of their body weight in the past 6 months. Additionally, those interested must be willing to participate in online/electronic surveys and virtual group meetings, without any contraindications that could impede safe and effective exercise training sessions."

Answered by AI

What is the present enrollment of this trial?

"Indeed, the information on clinicaltrials.gov attests to this trial being currently open for recruitment. This experiment was first published on August 12th 2020 and was recently updated in November 15th 2022. The research is looking for 150 patients from 1 site."

Answered by AI

Are geriatric individuals accepted into this trial?

"This particular study is only accepting patients aged 60-85. By comparison, there are 19 trials for younger participants and 172 research opportunities available to those over the age of 65."

Answered by AI

Who else is applying?

What state do they live in?
North Carolina
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
What site did they apply to?
Wake Forest University School of Medicine

Why did patients apply to this trial?

I am pursuing high resistance, high impact training (per the Liftmore study) before resorting to medications for my osteoporosis. I am 73 years old, active and committed to my chosen form of treatment.
PatientReceived 1 prior treatment
~32 spots leftby Apr 2025